Gey LL.M., Peter

Dr. Peter Gey, LL.M.

Dr. Peter Gey's practice focuses on European and German antitrust and competition law, European state aid law and regulation, with emphasis on the pharmaceutical and agro-chemical industries and the life science sector.

Dr. Gey also has substantial experience in public procurement law, in particular in relation to tenders of German public health funds for pharmaceuticals and medical devices.

Professional Activities

Dr. Gey is a member of the Association for the Study of Antitrust Law (Studienvereinigung Kartellrecht) and the German-American Lawyers Association. He has lectured on German and European antitrust and competition law at the University of Applied Sciences Frankfurt and regularly publishes in the field of antitrust law and regulation. Dr. Gey is a former Scholar of Deutscher Akademischer Austauschdienst (DAAD).

Experience

  • Advice to an international pharma company in the European Commission’s sector inquiry in the pharma sector
  • Securing first phase German merger control clearance of for two acquisitions of a major seed company
  • Represented various pharma companies in litigation relating to tender procedures by German public health funds for so-called rebate agreements ("Rabattverträge”), inter alia winning the first injunction for a pharma company against the multi-billion Euro rebate contract tender for pharmaceuticals 2008/09 of the biggest German public health fund. The litigation led to landmark decisions concerning the legal assessment of such rebate agreement tenders, including decisions of the Higher Social Court Stuttgart, the Federal Social Court and the Federal Civil Court.
  • Part of the team that advised an international flat glass producer in the European Commission’s flat glass price fixing investigation
  • Part of the team that advised the State of Hessen in state aid procedures before the European Commission relating to the financing of the Hessische Staatsweingüter and the regional airport of Kassel-Calden

Recognition

  • JUVE Handbook 2014/2015-2016/2017 recommends Dr. Gey as having a “very deep knowledge of the pharma industry, excellent advice in complex EU-law issues” for transactions in the healthcare sector.
  • JUVE Handbook 2016/2017 further recommends Dr. Gey in the area of state aid law.
  • Dr. Gey is recommended by Legal 500 Deutschland 2017 for having “very deep knowledge of the pharma industry” in the regulated industry: healthcare sector. 

Insights & News

Credentials